Polaris Partners

Name

Polaris Partners

Legal name

Polaris Growth Management, L.L.C., North Star Venture Management 2026, L.L.C., North Star Venture Management Legacy, L.L.C., LS Polaris Innovation Fund Management, L.L.C., and North Star Ventures SG Pte. Ltd. (collectively, Polaris Partners)

Website

https://polarispartners.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Venture Capital / Private Equity

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industries

Technology & Software Growth Equity (FSANACAA), Multi-Sector / Generalist Growth Equity (FSANACAO), Private Equity Fundraising Placement (FSAEALAB)

Keywords

• Venture capital investing
• Healthcare venture capital
• Biotechnology investments
• Growth equity funds
• Early-stage startup funding

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Management fees and carried interest: Polaris Partners generates revenue through management fees charged on funds under management and carried interest (performance fees) from successful portfolio exits. As a venture capital firm, the firm manages multiple fund vehicles including Polaris Main Funds (Polaris Venture Partners I through XI, Polaris Partners VII through XI, Polaris Healthcare Technology Opportunities Fund), Polaris Growth Funds (PGF I, PGF II, PGF III), and Polaris Innovation Funds (LSPIF, PIF II). The firm has achieved 100+ exits and 50+ IPOs among its portfolio companies, indicating significant carried interest generation over its nearly 30-year history.

Distribution channels1 record

Marketing channels4 records

Core offering

Polaris Partners is a venture capital firm that invests equity capital into early-stage and growth-stage healthcare and biotechnology companies. It deploys capital through three fund vehicles—Polaris Main Funds, the Polaris Innovation Fund (academic spinouts), and the Polaris Growth Fund (profitable technology companies)—while providing board-level guidance, operational support, and network access to portfolio company founders.

Product overview

Polaris Partners is a venture capital investment firm with nearly 30 years of experience backing transformational healthcare and biotech companies. The firm operates three distinct fund vehicles: the Polaris Main Funds (core VC funds with 400+ companies funded and 100+ exits), the Polaris Innovation Fund (early-stage academic spinout accelerator), and the Polaris Growth Fund (growth buyout strategy for profitable technology companies). Together these funds have helped bring 60+ therapies to market and achieved 50+ IPOs. The firm has offices in Boston, New York, and San Francisco, and manages investments across healthcare services, life sciences, biotechnology, and technology-enabled services.

Differentiator

Problem solved

Functional benefit

Brands

• Polaris Growth Fund: Supporting the growth and expansion of profitable, founder-owned technology companies.
• Polaris Innovation Fund

Products and services

• Polaris Main Funds (Polaris Venture Partners I–XI and Polaris Healthcare Technology Opportunities Fund) The core venture capital funds of Polaris Partners, investing equity capital in healthcare and biotechnology companies (drugs, diagnostics, devices, and technology-enabled services) across multiple stages from seed through growth across funds I–XI and the specialized Healthcare Technology Opportunities Fund; targeted at founders and management teams of healthcare and biotech companies.
• Polaris Innovation Fund (LSPIF / PIF II) A specialized affiliate fund managed by LS Polaris Innovation Fund Management, L.L.C., that accelerates the commercial and therapeutic potential of early-stage academic research by partnering with academic researchers to form new companies based on breakthrough science; targeted at academic researchers, universities, and research institutions.
• Polaris Growth Fund (PGF I, PGF II, PGF III) A specialized affiliate fund managed by Polaris Growth Management, L.L.C., that supports the growth and expansion of profitable, founder-owned technology companies through levered recapitalizations of software and technology-enabled services companies; targeted at founders and owners of profitable software and technology-enabled services businesses seeking capital and partnership.

Quantifiable outcome

• 400+ companies funded since 1996
• +7 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• Stanford MedicinecoreStrategic or Co-development PartnerMatter Neuroscience, a Polaris portfolio company, announced a clinical collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department in June 2025 for a controlled study enrolling at least 210 depressed patients using the Matter protocol combined with real-time 7T fMRI neurofeedback.
• Harvard Office of Technology DevelopmentminorStrategic or Co-development PartnerEllie McGuire serves as expert in residence for the Harvard Office of Technology Development, supporting academic technology commercialization and company formation from Harvard research.
• MIT (The Engine)minorStrategic or Co-development PartnerAmir Nashat serves on the Partners Innovation Fund and the Investment Advisory Committee for The Engine at MIT, helping support and fund companies commercializing tough-tech breakthroughs from MIT research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• New Enterprise Associates (NEA): NEA is a large multi-stage venture firm with a dedicated healthcare practice. While broader in sector coverage, it overlaps with Polaris on healthcare/biotech investments and fund scale across multiple vintages.
• Bessemer Venture Partners: Bessemer is a long-established multi-stage venture firm with a healthcare franchise. Like Polaris, it operates from multiple US offices, manages multiple fund vintages, and serves healthcare entrepreneurs with growth capital.
• Andreessen Horowitz (a16z) Bio: a16z is a large multi-stage venture firm with a dedicated bio/health fund investing in biotech and healthcare. Its breadth and mega-fund scale contrast with Polaris's specialist focus, but it represents a comparable LP-facing platform in the healthcare VC space.

Direct peers

• Atlas Venture: Atlas Venture is a Boston-based early-stage biotech venture capital firm building breakthrough science companies. Both firms operate from Boston, focus on company formation in biotech, and partner with entrepreneurs from academic and industry backgrounds.
• Flagship Pioneering: Flagship Pioneering is a healthcare-focused venture creation firm that originates and grows biotechnology companies from novel scientific platforms. Its venture-creation model and biotech focus closely parallel the Polaris Innovation Fund's academic spinout strategy.
• ARCH Venture Partners: ARCH Venture Partners is a leading early-stage healthcare and biotechnology venture capital firm with a similar stage focus and science-driven investment approach to Polaris Partners. Both firms partner with academic institutions and co-lead seed/Series A biotech financings (e.g., co-leadership of Matter Neuroscience).
• 5AM Ventures: 5AM Ventures is an early-stage venture capital firm focused on life sciences, with similar seed/Series A biotech investing and company-formation expertise. Both firms operate in the same Boston/Cambridge biotech ecosystem and back similar therapeutic platforms.
• RA Capital Management: RA Capital is a healthcare-focused crossover fund investing across public and private biotech. Both firms invest heavily in healthcare/biotech and frequently participate in similar Series B and crossover rounds with strategic syndicates.
• OrbiMed: OrbiMed is a leading healthcare-dedicated investment firm across venture, growth, and public equities. It is comparable to Polaris in its healthcare-only mandate and breadth across biotech, medical devices, and healthcare services.
• Third Rock Ventures: Third Rock Ventures is a healthcare venture firm focused on launching and building transformative life sciences companies. Like Polaris, it emphasizes company creation, provides deep operating support, and targets large patient-impact opportunities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Customer concentration

• LinkedInlinkedin.com/company/polaris-partners
• Xx.com/PolarisVC
• Facebookfacebook.com/Polaris-Partners-404737049642094

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments776 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polaris Partners